Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History
About Eichenfield Lawrence
Eichenfield Lawrence (SEC CIK 0001814892) files insider reports with the SEC as Director of Verrica Pharmaceuticals Inc. (VRCA).
Signal8 holds 2 ownership filings by Eichenfield Lawrence, all Form 4s, filed between Jun 9, 2025 and Jun 9, 2026. Those filings report 2 transactions, the latest on Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Eichenfield Lawrence's filings is in WEST CHESTER, PA.
Other insiders filing for Verrica Pharmaceuticals Inc. (VRCA)
- Zawitz David, Chief Operating Officer
- Rieger Jayson, CEO and President
- Rosenberg Noah L., CMO
- Kirby John J., Interim CFO
- Nguyen Diem, Director
- PRYGOCKI MARK A SR, Director